AKT1 and pancreatic neoplasm: Exposure of orthotopic pancreatic tumors to LY294002 resulted in dose-dependent inhibition of tumor growth, and decreased peritoneal and liver metastases, effects that were associated with an inhibition of Akt phosphorylation and increased apoptosis [430].